MX2018002921A - Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada. - Google Patents
Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada.Info
- Publication number
- MX2018002921A MX2018002921A MX2018002921A MX2018002921A MX2018002921A MX 2018002921 A MX2018002921 A MX 2018002921A MX 2018002921 A MX2018002921 A MX 2018002921A MX 2018002921 A MX2018002921 A MX 2018002921A MX 2018002921 A MX2018002921 A MX 2018002921A
- Authority
- MX
- Mexico
- Prior art keywords
- stimulating hormone
- increased stability
- hormone composition
- follicle
- mammalian follicle
- Prior art date
Links
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 title 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 title 1
- 229940028334 follicle stimulating hormone Drugs 0.000 title 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 abstract 2
- 102000006771 Gonadotropins Human genes 0.000 abstract 1
- 108010086677 Gonadotropins Proteins 0.000 abstract 1
- 102000003864 Human Follicle Stimulating Hormone Human genes 0.000 abstract 1
- 108010082302 Human Follicle Stimulating Hormone Proteins 0.000 abstract 1
- 229960002242 chlorocresol Drugs 0.000 abstract 1
- 239000002622 gonadotropin Substances 0.000 abstract 1
- 229940094892 gonadotropins Drugs 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere al campo de gonadotropinas. En particular, se proporciona una composición mejorada que comprende hormona folículo-estimulante humana recombinante y clorocresol. Esta composición mejorada tiene una estabilidad incrementada a altas temperaturas y es útil en el tratamiento de infertilidad, en particular en pacientes humanos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU92831 | 2015-09-17 | ||
PCT/EP2016/071917 WO2017046295A1 (en) | 2015-09-17 | 2016-09-16 | Mammalian follicle-stimulating hormone composition with increased stability |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018002921A true MX2018002921A (es) | 2018-12-10 |
Family
ID=54256805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018002921A MX2018002921A (es) | 2015-09-17 | 2016-09-16 | Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20180264086A1 (es) |
EP (1) | EP3349728A1 (es) |
JP (1) | JP7255050B2 (es) |
KR (1) | KR20180052128A (es) |
CN (2) | CN108348465B (es) |
AU (1) | AU2016323541A1 (es) |
BR (1) | BR112018003455A2 (es) |
CA (1) | CA2994044A1 (es) |
EA (1) | EA201890163A1 (es) |
IL (1) | IL257815A (es) |
MX (1) | MX2018002921A (es) |
WO (1) | WO2017046295A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018002921A (es) | 2015-09-17 | 2018-12-10 | Glycotope Gmbh | Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada. |
CN109731097A (zh) * | 2018-12-25 | 2019-05-10 | 长春圣金诺生物制药有限公司 | 一种rh-FSH制剂及其制备方法 |
KR102357795B1 (ko) * | 2019-04-19 | 2022-02-04 | 한양대학교 산학협력단 | 포스파티딘산 함유 온도 감응성 조성물 및 이의 용도 |
KR20230133595A (ko) | 2022-03-11 | 2023-09-19 | 한국한의약진흥원 | 등검은말벌독에 함유된 세로토닌의 안정성을 유지하기 위한 조성물 |
CN115429751B (zh) * | 2022-09-21 | 2023-11-17 | 景泽生物医药(合肥)股份有限公司 | 一种人重组卵泡刺激素注射剂及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5272135A (en) | 1991-03-01 | 1993-12-21 | Chiron Ophthalmics, Inc. | Method for the stabilization of methionine-containing polypeptides |
JP4719357B2 (ja) * | 1998-07-23 | 2011-07-06 | アレス トレイディング ソシエテ アノニム | Fsh及びfsh変異体の製剤、製品及び方法 |
EP2325194A1 (en) | 2009-11-24 | 2011-05-25 | Glycotope GmbH | Process for the purification of glycoproteins |
CN102821782B (zh) * | 2010-02-12 | 2015-07-15 | 印塔斯生物制药有限公司 | 促卵泡激素的液体配制品 |
WO2012016576A1 (en) | 2010-08-04 | 2012-02-09 | Glycotope Gmbh | Improved recombinant human follicle-stimulating hormone |
WO2012168680A1 (en) * | 2011-06-06 | 2012-12-13 | Ferring B.V. | Pharmaceutical preparation comprising recombinant fsh |
JO3092B1 (ar) * | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
MX2018002921A (es) | 2015-09-17 | 2018-12-10 | Glycotope Gmbh | Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada. |
-
2016
- 2016-09-16 MX MX2018002921A patent/MX2018002921A/es unknown
- 2016-09-16 AU AU2016323541A patent/AU2016323541A1/en not_active Abandoned
- 2016-09-16 BR BR112018003455A patent/BR112018003455A2/pt not_active Application Discontinuation
- 2016-09-16 CN CN201680053479.2A patent/CN108348465B/zh active Active
- 2016-09-16 JP JP2018514276A patent/JP7255050B2/ja active Active
- 2016-09-16 KR KR1020187010735A patent/KR20180052128A/ko not_active Application Discontinuation
- 2016-09-16 EP EP16767244.3A patent/EP3349728A1/en active Pending
- 2016-09-16 CA CA2994044A patent/CA2994044A1/en not_active Abandoned
- 2016-09-16 US US15/760,846 patent/US20180264086A1/en not_active Abandoned
- 2016-09-16 CN CN202011131350.3A patent/CN113198005A/zh active Pending
- 2016-09-16 EA EA201890163A patent/EA201890163A1/ru unknown
- 2016-09-16 WO PCT/EP2016/071917 patent/WO2017046295A1/en active Application Filing
-
2018
- 2018-03-01 IL IL257815A patent/IL257815A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN108348465B (zh) | 2020-11-10 |
IL257815A (en) | 2018-04-30 |
BR112018003455A2 (pt) | 2018-09-25 |
AU2016323541A1 (en) | 2018-04-12 |
KR20180052128A (ko) | 2018-05-17 |
US20180264086A1 (en) | 2018-09-20 |
EP3349728A1 (en) | 2018-07-25 |
CA2994044A1 (en) | 2017-03-23 |
JP7255050B2 (ja) | 2023-04-11 |
JP2018528224A (ja) | 2018-09-27 |
WO2017046295A1 (en) | 2017-03-23 |
CN113198005A (zh) | 2021-08-03 |
EA201890163A1 (ru) | 2018-10-31 |
CN108348465A (zh) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018002921A (es) | Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada. | |
WO2016070166A3 (en) | Messenger una molecules and uses thereof | |
SG10201811454WA (en) | Materials and methods for controlling infections | |
MX2019015311A (es) | Composiciones de ésteres de ácido cannabidiólico y usos de las mismas. | |
MX2017001279A (es) | Usos y composiciones de la flagelina. | |
MX336489B (es) | Hormona foliculo estimulante humana recombinante composicion farmaceutica que la comprende y uso de la misma. | |
MX2015015249A (es) | Peptidos terapeuticos. | |
CY1117214T1 (el) | Συνθεση για ελεγχομενη διεγερση των ωοθηκων | |
MX2017010883A (es) | Composicion para el tratamiento de la infertilidad. | |
MX2016013449A (es) | Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada. | |
PH12021550122A1 (en) | Solubilized apyrases, methods and use | |
MX2015016492A (es) | Peptidos de y conotoxina, composicion farmaceutica y usos de los mismos. | |
MX2017013795A (es) | Combinaciones terapeuticas de tratamientos antivirales y antiinflamatorios. | |
PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
PH12015502564B1 (en) | Pyridone derivatives for the treatment of viral infections and further diseases | |
MY197247A (en) | Recombinant glycoproteins and uses thereof | |
PH12017500816A1 (en) | Long acting pharmaceutical compositions for hepatitis c | |
PH12017500820A1 (en) | Combination long acting compositions and methods for hepatitis c | |
MX2017013879A (es) | Composiciones que comprenden anakinra. | |
PH12020500404A1 (en) | Composition for controlled ovarian stimulation | |
MX2015014222A (es) | Composiciones farmaceuticas comprendiendo kisspeptina o sus derivados y metodo de preparacion de dichas composiciones. | |
IN2013MU02576A (es) | ||
EA201791103A1 (ru) | Терапевтический гомодимер и его применения |